selinexor,Ruxolitinib
karyopharm therapeutics,novartis,incyte
['selinexor']
karyopharm announces presentation of updated phase 1 selinexor data in patients with treatment-na ve myelofibrosis at aacr 2023 $kpti #aacr23 
No investment advice. Do your own DD Market is all about taking the shares from the weak holders& providing opportunities to those that have the stamina to hold